AU2110000A - Use of substituted isoxazol carboxylic acids and derivatives and novel substances - Google Patents
Use of substituted isoxazol carboxylic acids and derivatives and novel substancesInfo
- Publication number
- AU2110000A AU2110000A AU21100/00A AU2110000A AU2110000A AU 2110000 A AU2110000 A AU 2110000A AU 21100/00 A AU21100/00 A AU 21100/00A AU 2110000 A AU2110000 A AU 2110000A AU 2110000 A AU2110000 A AU 2110000A
- Authority
- AU
- Australia
- Prior art keywords
- derivatives
- carboxylic acids
- novel substances
- substituted isoxazol
- isoxazol carboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- UXYRXGFUANQKTA-UHFFFAOYSA-N 1,2-oxazole-3-carboxylic acid Chemical class OC(=O)C=1C=CON=1 UXYRXGFUANQKTA-UHFFFAOYSA-N 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19904389 | 1999-02-04 | ||
| DE19904389A DE19904389A1 (en) | 1999-02-04 | 1999-02-04 | Use of substituted isoxazolecarboxylic acids and derivatives and new substances |
| PCT/EP2000/000517 WO2000045799A2 (en) | 1999-02-04 | 2000-01-24 | Use of substituted isoxazol carboxylic acids and derivatives and novel substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2110000A true AU2110000A (en) | 2000-08-25 |
Family
ID=7896332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21100/00A Abandoned AU2110000A (en) | 1999-02-04 | 2000-01-24 | Use of substituted isoxazol carboxylic acids and derivatives and novel substances |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR022469A1 (en) |
| AU (1) | AU2110000A (en) |
| DE (1) | DE19904389A1 (en) |
| GT (1) | GT200000011A (en) |
| WO (1) | WO2000045799A2 (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998037068A1 (en) | 1997-02-21 | 1998-08-27 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
| MY151199A (en) | 2001-11-02 | 2014-04-30 | Rigel Pharmaceuticals Inc | Substituted diphenyl heterocycles useful for treating hcv infection |
| JP2006501312A (en) | 2002-08-23 | 2006-01-12 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Pyridyl-substituted heterocycles useful for treating or preventing HCV infection |
| US7115642B2 (en) | 2003-05-02 | 2006-10-03 | Rigel Pharmaceuticals, Inc. | Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection |
| US7326790B2 (en) | 2003-05-02 | 2008-02-05 | Rigel Pharmaceuticals, Inc. | Diphenylisoxazole compounds and hydro isomers thereof |
| US7220745B2 (en) | 2003-05-15 | 2007-05-22 | Rigel Pharmaceuticals | Heterocyclic compounds useful to treat HCV |
| US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| US7410979B2 (en) | 2003-11-19 | 2008-08-12 | Rigel Pharmaceuticals, Inc. | Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections |
| US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
| WO2006044456A1 (en) | 2004-10-13 | 2006-04-27 | Ptc Therapeutics, Inc. | Compounds for nonsense suppression, and methods for their use |
| CN101203498A (en) | 2005-05-02 | 2008-06-18 | 里格尔药品股份有限公司 | Heterocyclic antiviral compounds including metabolizable moieties and uses thereof |
| EP1893591A1 (en) * | 2005-06-08 | 2008-03-05 | Novartis AG | POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
| GB0601744D0 (en) * | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
| AR062683A1 (en) | 2006-09-07 | 2008-11-26 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM PIRIDIN-4-ILO, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE OF THE SAME IN THE PREPARATION OF MEDICINES |
| DK2069335T3 (en) * | 2006-09-08 | 2013-02-18 | Actelion Pharmaceuticals Ltd | PYRIDIN-3-YLD DERIVATIVES AS IMMUNO MODULATORS |
| US20080167286A1 (en) | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
| US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
| UY30846A1 (en) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES |
| EP2125797B1 (en) | 2007-03-16 | 2014-01-15 | Actelion Pharmaceuticals Ltd. | Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| WO2009029632A1 (en) | 2007-08-27 | 2009-03-05 | Helicon Therapeutics, Inc. | Therapeutic isoxazole compounds |
| MX2010006202A (en) | 2007-12-07 | 2011-03-04 | Abbott Gmbh & Co Kg | Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses. |
| WO2010009775A1 (en) | 2007-12-07 | 2010-01-28 | Abbott Gmbh & Co. Kg | Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| CA2707669C (en) | 2007-12-07 | 2016-07-05 | Wilfried Braje | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| WO2009071690A2 (en) | 2007-12-07 | 2009-06-11 | Abbott Gmbh & Co. Kg | 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| WO2010138600A2 (en) | 2009-05-29 | 2010-12-02 | Abbott Laboratories | Pharmaceutical compositions for the treatment of pain |
| WO2011005660A1 (en) | 2009-07-08 | 2011-01-13 | Valocor Therapeutics, Inc. | Tofa analogs useful in treating dermatological disorders or conditions |
| SG178042A1 (en) | 2009-07-16 | 2012-03-29 | Actelion Pharmaceuticals Ltd | Pyridin-4-yl derivatives |
| SI2665720T1 (en) | 2011-01-19 | 2015-08-31 | Actelion Pharmaceuticals Ltd. | 2-methoxy-pyridin-4-yl derivatives |
| CN102329277B (en) * | 2011-10-24 | 2013-08-07 | 海南霞迪药业有限公司 | Method for preparing Parecoxib |
| US10385043B2 (en) | 2015-05-20 | 2019-08-20 | Idorsia Pharmaceuticals Ltd | Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol |
| CN116535399B (en) * | 2022-01-25 | 2024-02-27 | 中国药科大学 | 3-hydroxy-5- (isoxazol-5-yl) pyridine formyl glycine compound, preparation method, pharmaceutical composition and application |
| WO2024029638A1 (en) * | 2022-08-01 | 2024-02-08 | 한국과학기술연구원 | Novel heterocyclyl-phenyl-methylamine derivative, preparation method therefor, and use thereof for prevention, alleviation, or treatment of multiple sclerosis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB149877A (en) * | 1919-11-22 | 1920-08-26 | Arthur William Wells | Improvements in and in connection with safety razors |
| ES488768A0 (en) * | 1979-02-22 | 1981-02-16 | Monsanto Co | A PROCEDURE FOR PREPARING ACID 2- (3-ARIL-5-ISOXAZOLIL) -BENZOIC |
| US5330994A (en) * | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
| DE4314966A1 (en) * | 1993-05-06 | 1994-11-10 | Fahlberg List Pharma Gmbh | 2-Hydroxyphenyl-substituted isoxazoles, the use thereof as pharmaceutical agents and pharmaceutical compositions containing them |
| WO1997019039A1 (en) * | 1995-11-17 | 1997-05-29 | Novartis Ag | Solid phase synthesis of heterocyclic compounds and combinatorial compound library |
| DE19640370C1 (en) * | 1996-09-30 | 1998-02-12 | Dornier Gmbh Lindauer | Assemblies to hold and guide loom shaft rods |
| EP0994101A4 (en) * | 1997-06-18 | 2002-05-02 | Fujisawa Pharmaceutical Co | New production process |
-
1999
- 1999-02-04 DE DE19904389A patent/DE19904389A1/en not_active Withdrawn
-
2000
- 2000-01-24 WO PCT/EP2000/000517 patent/WO2000045799A2/en not_active Ceased
- 2000-01-24 AU AU21100/00A patent/AU2110000A/en not_active Abandoned
- 2000-02-01 AR ARP000100427A patent/AR022469A1/en unknown
- 2000-02-03 GT GT200000011A patent/GT200000011A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000045799A3 (en) | 2002-01-24 |
| WO2000045799A2 (en) | 2000-08-10 |
| GT200000011A (en) | 2001-07-27 |
| AR022469A1 (en) | 2002-09-04 |
| DE19904389A1 (en) | 2000-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2110000A (en) | Use of substituted isoxazol carboxylic acids and derivatives and novel substances | |
| PL351898A1 (en) | O-substituted derivatives of carboxylic acids | |
| AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
| HUP0105027A3 (en) | Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use | |
| AU3866597A (en) | Propionic acid derivatives and use thereof | |
| AU3312100A (en) | Hydroxamic and carboxylic acid derivatives | |
| AU6340899A (en) | Oxime derivatives and the use thereof as latent acids | |
| AU5373999A (en) | New unsaturated oxime derivatives and the use thereof as latent acids | |
| SG78412A1 (en) | Oxime derivatives and the use thereof as latent acids | |
| AU2001252272A1 (en) | Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis | |
| AU3942797A (en) | Orally applicable formulation of quinolone or naphthyridone carboxylic acids | |
| AU4161797A (en) | Benzoperimidine-carboxylic acids and derivatives thereof | |
| AU2003210402A1 (en) | Amides of acetic and propionic acids | |
| IL126027A0 (en) | Novel carboxylic acid derivatives their preparation and use | |
| ZA973096B (en) | Novel carboxylic acid derivatives their preparation and use | |
| MXPA03004938A (en) | Process and ester derivatives for preparation of cephalosporins. | |
| AU6557800A (en) | Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids | |
| AU4701299A (en) | Therapeutic applications of estrogenic carboxylic acids | |
| AU5814696A (en) | The preparation of carboxylic acid derivatives | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| AU6557700A (en) | Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids | |
| AU2002212176A1 (en) | Substituted phenylcyclohexane carboxylic acid amides and the use thereof | |
| AU2001223818A1 (en) | Co-production of carboxylic acids and/or their esters | |
| AU4595800A (en) | Hydroxamic and carboxylic acid derivatives | |
| GB9907082D0 (en) | The preparation of carboxylic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |